HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites
 


Biogen Idec Company News

Thu, 25 Apr 2019 10:48:43 GMT
Cytori Therapeutics, Inc. (CYTX) Trades at $0.31 After Triangle; Biogen Idec Has 0.91 Sentiment - The EN Herald
<ol><li> Cytori Therapeutics, Inc. (CYTX) Trades at $0.31 After Triangle; Biogen Idec Has 0.91 Sentiment The EN Herald</font></li><li><a href="/url/?u=https://www.barrons.com/articles/biogen-earnings-preview-51555962029" target="_blank">Biogen Reports Earnings Tomorrow. Here’s What to Expect. Barron's</font></li><li><a href="/url/?u=https://cryptocoinstribune.com/as-biogen-biib-market-value-declined-oak-associates-ltd-has-lifted-its-holding-by-2-53-million-regal-investment-advisors-holding-in-salesforce-com-crm-upped-as-stock-value-rose/" target="_blank">As Biogen (BIIB) Market Value Declined, Oak Associates LTD Has Lifted Its Holding by $2.53 Million; Regal Investment Advisors Holding in Salesforce Com (CRM) Upped as Stock Value Rose CryptoCoinsTribune</font></li><li><a href="/url/?u=https://nbonews.com/tortoise-energy-infrstrctr-c-tyg-shareholder-horizon-kinetics-has-trimmed-its-stake-biogen-biib-holder-highvista-strategies-trimmed-position-by-1-38-million-as-share-value-declined/" target="_blank">Tortoise Energy Infrstrctr C (TYG) Shareholder Horizon Kinetics Has Trimmed Its Stake; Biogen (BIIB) Holder Highvista Strategies Trimmed Position by $1.38 Million as Share Value Declined The NBO News</font></li><li><strong><a href="/url/?u=https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlobDczcmpZQU1FVkNfcXFfdTMydjhLQUFQAQ?oc=5" target="_blank">View full coverage on Google News</a></strong></li></ol>
Mon, 06 May 2019 15:20:00 GMT
Weekly CEO Buys Highlight - Yahoo Finance
Weekly CEO Buys Highlight Yahoo Finance Details the CEO buys this past week for the following companies: Biogen, Archer-Daniels Midland, GrubHub, Sealed Air, and Sally Beauty Holdings.
Thu, 09 May 2019 17:10:51 GMT
Hematological Disorders Diagnostic Therapeutic Market 2021: Top Key Players Biogen Idec, Inc., Bristol-Myers Squibb - New Daily Herald
Hematological Disorders Diagnostic Therapeutic Market 2021: Top Key Players Biogen Idec, Inc., Bristol-Myers Squibb New Daily Herald Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells ...
Fri, 10 May 2019 06:25:00 GMT
Massive growth of Biosimilar of Remicade Market 2025 with key players such as Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc., Genentech (Roche Group), and more.. - Market Research Updates
Massive growth of Biosimilar of Remicade Market 2025 with key players such as Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc., Genentech (Roche Group), and more.. Market Research Updates “Industry Overview of the Report 2025: The Global Biosimilar of Remicade Market report offers a detailed analysis of the global Biosimilar of Remicade market.
Tue, 07 May 2019 11:06:28 GMT
Hemoglobinopathies Drugs Market Key Player Analysis By | Gamida Cell, Alnylam Pharmaceuticals, Biogen Idec, Sangamo BioSciences Inc. - Industry Analysis
Hemoglobinopathies Drugs Market Key Player Analysis By | Gamida Cell, Alnylam Pharmaceuticals, Biogen Idec, Sangamo BioSciences Inc. Industry Analysis A new market assessment report on the Hemoglobinopathies Drugs market provides a comprehensive overview of the Hemoglobinopathies Drugs industry for ...
Thu, 09 May 2019 14:16:24 GMT
Rheumatoid Arthritis and Lupus Treatments Market by Manufacturers: AbbVie, Amgen, Bayer, Biogen Idec - Fox World Media
Rheumatoid Arthritis and Lupus Treatments Market by Manufacturers: AbbVie, Amgen, Bayer, Biogen Idec Fox World Media The global Rheumatoid Arthritis and Lupus Treatments report to 2024 covers the market background and its growth prospects on the upcoming years ...
Fri, 10 May 2019 07:53:54 GMT
Comparison of Merck & Co. Inc. (MRK) and Biogen Inc. (NASDAQ:BIIB) - The EN Herald
Comparison of Merck & Co. Inc. (MRK) and Biogen Inc. (NASDAQ:BIIB) The EN Herald We will be contrasting the differences between Merck & Co. Inc. (NYSE:MRK) and Biogen Inc. (NASDAQ:BIIB) as far as profitability, institutional ownership,
Sun, 28 Apr 2019 07:00:00 GMT
Global Interferon Market 2018 – Biogen Idec, Merck, Bayer, Roche, MSD - The Market Research News
Global Interferon Market 2018 – Biogen Idec, Merck, Bayer, Roche, MSD The Market Research News A new research by Innovate Insights on Interferon gives complete guidance which provides the most recent Interferon industry patterns like market development ...
Mon, 06 May 2019 17:15:04 GMT
Solid Tumor Therapeutics Market 2024: Top Key Players Biogen Idec, Inc, Boehringer Ingelheim GmbH - Whopp News
Solid Tumor Therapeutics Market 2024: Top Key Players Biogen Idec, Inc, Boehringer Ingelheim GmbH Whopp News In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst. These solid tumors are of two types namely ...
Thu, 02 May 2019 16:02:35 GMT
Ivor Royston Named Xconomy's 2019 Lifetime Achievement Award Winner in San Diego - Xconomy
Ivor Royston Named Xconomy's 2019 Lifetime Achievement Award Winner in San Diego Xconomy We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime.